Cite
APA Citation
Pennipede, D., Mohyuddin, G. R., Hawkins, R., Ganguly, S., Shune, L., Ahmed, N., Mohan, M., Cui, W., Mahmoudjafari, Z., McGuirk, J., Atrash, S., & Abdallah, A. (2021). carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple‐class relapsed/refractory multiple myeloma (RRMM). European journal of haematology, 107, 602–608. http://access.bl.uk/ark:/81055/vdc_100145494380.0x00003b